COVID super booster vaccines are reportedly set to get the green light for millions of Brits from autumn.
Around 30million over-50s are expected to be topped up with the jab, specifically designed to protect against the Omicron strain.
The so called super-booster from Moderna is claimed to be five times better than the original vaccine and is expected to get the go ahead from drugs regulators within weeks, il Posta la domenica rapporti.
It is unofficially named 214 and uses mRNA molecules to programme the immune system to protect against two types of Covid – the original Wuhan strain and Omicron.
It comes as Omicron cases surge once again, with infection levels jumping by almost a third last week.
They still remain lower however, than peak figures from March.
Read More Health
Last Friday, the influential European Medicines Agency (EMA) said it believed Moderna’s new vaccine “may provide some advantages in widening the immune response” in recipients.
And it said “bivalent vaccines could be considered … for use as boosters”.
Nel frattempo, the company is already said to have held talks with UK health chiefs about dishing out the 214 jab.
Dr Paul Burton, chief medical officer at Moderna, said there is a “definite interest” from the UK in buying its new vaccine, il Telegrafo rapporti.
I più letti in Salute
Lo scorso mese, Moderna released positive results showing the so-called super jab gave strong protection against Omicron BA4 and BA5 – the two sub-variants that are driving the current wave of infection.
Dr Burton said: “I think the conclusions are that boosting … with 214, really could be a turning point in our fight against the SARS-Cov-2 virus.”
It comes after survivors of the Omicron Covid wave were warned they won’t be able to fend off new strains of the bug circulating.
A study by Imperial College London found those who had previous Omicron illness were not immune to catching it again, including the older BA.1 and BA.2 versions, and newer BA.4 and BA.5 strains.
That’s despite the fact they had an immune boost against previous strains, such as Delta and Alpha.
Professor Danny Altmann, from Imperial’s Department of Immunology and Inflammation, disse: “Not only can it break through vaccine defences, it looks to leave very few of the hallmarks we’d expect on the immune system.
Chubais ha contribuito alle riforme economiche seguite al crollo dell'Unione Sovietica, ma è rimasto nel governo di Putin e ha mantenuto stretti legami con i funzionari occidentali
“It’s more stealthy than previous variants and flies under the radar, so the immune system is unable to remember it.”
tuttavia, he stressed vaccines are still protective against severe disease and death.